3.0.0 1128 2023-01-11T13:24:41Z 2023-01-11T13:24:41Z Senate S S 2013-06-11 113 ssfi00 Finance Committee Senate Standing Referred to 2013-06-11T15:06:02Z Preserving Access to Orphan Drugs Act of 2013 113 2315 HR 2013-07-25 Rereferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Identical bill CRS 2013-06-11 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2013-06-11 Introduced in Senate IntroReferral 10000 9 Library of Congress T000461 Sen. Toomey, Patrick [R-PA] Patrick Toomey R PA J. N C001070 Sen. Casey, Robert P., Jr. [D-PA] Bob Casey D PA 2013-06-11 True C000880 Sen. Crapo, Mike [R-ID] Mike Crapo R ID 2013-06-11 True C000174 Sen. Carper, Thomas R. [D-DE] Thomas Carper D DE R. 2013-07-23 False W000437 Sen. Wicker, Roger F. [R-MS] Roger Wicker R MS F. 2013-07-24 False R000595 Sen. Rubio, Marco [R-FL] Marco Rubio R FL 2014-01-08 False M001169 Sen. Murphy, Christopher [D-CT] Christopher Murphy D CT S. 2014-06-26 False Health Health care costs and insurance Prescription drugs User charges and fees Health 00 2013-06-11 Introduced in Senate 2013-07-05T15:15:38Z Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million.

Makes this Act effective as if included in PPACA.

]]> Preserving Access to Orphan Drugs Act of 2013 Display Title Preserving Access to Orphan Drugs Act of 2013 Official Title as Introduced A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers. Introduced in Senate IS Short Titles as Introduced Preserving Access to Orphan Drugs Act of 2013 Introduced in Senate 2013-06-11T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113s1128is/xml/BILLS-113s1128is.xml 2013-06-11 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.